These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Ototoxicity of cisplatin in gynaecological cancer patients.
    Author: Laurell G, Borg E.
    Journal: Scand Audiol; 1988; 17(4):241-7. PubMed ID: 3232027.
    Abstract:
    The ototoxic side effect of a moderate dose of cisplatin was studied by regular audiometric investigations in 186 women with gynaecologic cancer. Cisplatin was given in a dose of 50 mg/m2 body surface by intravenous infusion every 4 weeks. High-frequency hearing loss occurred in 40 patients (22%), but in no single case was a significant change observed in the frequency range of 0.5-2 kHz. Older patients showed a statistically significant greater incidence of audiometric changes, but the pretreatment audiogram was not a predictor for ototoxic changes. It is concluded that a moderate dose of cisplatin does not effect the ability to communicate.
    [Abstract] [Full Text] [Related] [New Search]